Ask Warren

NGeneBio

354200 · KOSDAQ · ₩354200 · 엔젠바이오

₩642▼ ₩23 (3.46%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • 5%+ holding report주식등의대량보유상황보고서(약식)Oct 8, 2026Open on DART
  • Other Market Notice기타시장안내Oct 7, 2026Open on DART
  • Other Market Notice (Potential Designation as Administrative Issue – Market Capitalization Below ₩20B)기타시장안내(관리종목지정우려종목) (시가총액 200억원 미달)Sep 22, 2026Open on DART
  • [Amended] Results of Securities Issuance (Voluntary Disclosure)[기재정정]증권발행결과(자율공시)Sep 22, 2026Open on DART
  • [Amended] Securities Issuance Performance Report[기재정정]증권발행실적보고서Sep 22, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Sep 22, 2026Open on DART
  • Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득Sep 18, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Sep 17, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 17, 2026Open on DART
  • Securities Issuance Results Report증권발행실적보고서Sep 17, 2026Open on DART
  • Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의청약결과(자율공시)Sep 16, 2026Open on DART
  • Change of CEO대표이사변경Sep 15, 2026Open on DART
  • Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의청약결과(자율공시)Sep 11, 2026Open on DART
  • Final Determination of Issue Price for Rights Offering유상증자최종발행가액확정Sep 7, 2026Open on DART
  • Amended: Prospectus[기재정정]투자설명서Sep 7, 2026Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Sep 7, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Sep 7, 2026Open on DART
  • Amended: Prospectus[기재정정]투자설명서Aug 20, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Aug 20, 2026Open on DART
  • Occurrence of Derivatives Trading Loss파생상품거래손실발생Aug 14, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 14, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 14, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 7, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 29, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 29, 2026Open on DART
  • Ex-Rights Date (Rights Offering)권리락 (유상증자)Jul 20, 2026Open on DART
  • Determination of Issue Price for First Tranche of Rights Offering유상증자1차발행가액결정Jul 20, 2026Open on DART
  • Prospectus투자설명서Jul 20, 2026Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Jul 20, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jul 20, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Jul 16, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jul 16, 2026Open on DART
  • Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Jul 10, 2026Open on DART
  • Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(일반)Jul 10, 2026Open on DART
  • Amended: Insider shareholding report[기재정정]임원ㆍ주요주주특정증권등소유상황보고서Jul 10, 2026Open on DART
  • Trading halt주권매매거래정지해제 (감자 주권 변경상장)Jul 8, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Jul 2, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jul 2, 2026Open on DART
  • Capital Reduction Completed감자완료Jun 29, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 26, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 26, 2026Open on DART
  • Trading halt주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)Jun 18, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Jun 18, 2026Open on DART
  • Results of Extraordinary Shareholders' Meeting임시주주총회결과Jun 9, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류May 22, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고May 22, 2026Open on DART
  • Securities registration statement증권신고서(지분증권)May 19, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Apr 27, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: NGeneBio / 엔젠바이오 / 354200 / KRX:354200

Source: KRX statistical information